ConductScience.org, home

Paper42226197

Supramolecular coordination nanoplatform amplifies oxidative stress to overcome ferroptosis resistance in gallbladder cancer.

Zhao Y and 13 others. J Nanobiotechnology, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Supramolecular coordination nanoplatform amplifies oxidative stress to overcome ferroptosis resistance in gallbladder cancer. Papers, record 42226197. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42226197

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Supramolecular coordination nanoplatform amplifies oxidative stress to overcome ferroptosis resistance in gallbladder cancer.
PubMed
Journal
J Nanobiotechnology
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhao YYuhao
2Zhang JJingyun
3Zhou CChen
4Yang MMao
5Zheng ZZhigang
6Gu YYixiang
7Zhang YYang
8Chen XXingqi
9Zhou ZZhengjun
10Gu JJin
11Zhao LLijin
12Wu WWenguang
13Lang MMeidong
14Liu YYingbin

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
FerroptosisMajor topic
Oxidative StressMajor topic
Gallbladder NeoplasmsMajor topic
Humans
Animals
Cell Line, Tumor
Mice
Reactive Oxygen Species
Tumor Microenvironment
Porphyrins
Chlorophyllides
Female
Antioxidants
Antineoplastic Agents
Iron

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
No. 82504141the National Natural Science Foundation of ChinaPubMed
No. 32130036the National Natural Science Foundation of ChinaPubMed
10000015Z155080000004the National Clinical Key Specialty Construction ProjectPubMed
No. Qiankeherencai XKBF [2025]025Guizhou Provincial Science and Technology ProjectsPubMed

Source PubMed

Download CSV of grants

References32

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125602130Nanoparticles in photodynamic therapy.Chem Rev2015https://conductscience.org/library/papers/25602130PubMed
238551494Diselenide-Containing Polymer Based on New Antitumor Mechanism as Efficient GSH Depletion Agent for Ferroptosis Therapy.Adv Healthc Mater2024https://conductscience.org/library/papers/38551494PubMed
337488674Isoliquiritigenin induces HMOX1 and GPX4-mediated ferroptosis in gallbladder cancer cells.Chin Med J (Engl)2023https://conductscience.org/library/papers/37488674PubMed
432985258The effects and mechanisms of isoliquiritigenin loaded nanoliposomes regulated AMPK/mTOR mediated glycolysis in colorectal cancer.Artif Cells Nanomed Biotechnol2020https://conductscience.org/library/papers/32985258PubMed
531484489Contemporary perspectives on the use of radiation therapy for locally advanced gallbladder cancer.Chin Clin Oncol2019https://conductscience.org/library/papers/31484489PubMed
633846504Patient-derived organoids as a predictive biomarker for treatment response in cancer patients.NPJ Precis Oncol2021https://conductscience.org/library/papers/33846504PubMed
725237826Three-dimensional organotypic culture: experimental models of mammalian biology and disease.Nat Rev Mol Cell Biol2014https://conductscience.org/library/papers/25237826PubMed
836610291Overcoming cancer chemotherapy resistance by the induction of ferroptosis.Drug Resist Updat2023https://conductscience.org/library/papers/36610291PubMed
934580933Manipulating Intratumoral Fenton Chemistry for Enhanced Chemodynamic and Chemodynamic-Synergized Multimodal Therapy.Adv Mater2021https://conductscience.org/library/papers/34580933PubMed
1022632970Ferroptosis: an iron-dependent form of nonapoptotic cell death.Cell2012https://conductscience.org/library/papers/22632970PubMed
1140068597Multimodal integration of liquid biopsy and radiology for the noninvasive diagnosis of gallbladder cancer and benign disorders.Cancer Cell2025https://conductscience.org/library/papers/40068597PubMed
1231896010Isoliquiritigenin triggers developmental toxicity and oxidative stress-mediated apoptosis in zebrafish embryos/larvae via Nrf2-HO1/JNK-ERK/mitochondrion pathway.Chemosphere2020https://conductscience.org/library/papers/31896010PubMed
1329274359Heme oxygenase-1 mediates BAY 11-7085 induced ferroptosis.Cancer Lett2018https://conductscience.org/library/papers/29274359PubMed
1432532289A novel patient-derived organoids-based xenografts model for preclinical drug response testing in patients with colorectal liver metastases.J Transl Med2020https://conductscience.org/library/papers/32532289PubMed
1539953537Eriodictyol-cisplatin coated nanomedicine synergistically promote osteosarcoma cells ferroptosis and chemosensitivity.J Nanobiotechnology2025https://conductscience.org/library/papers/39953537PubMed
1636372281Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.Ann Oncol2023https://conductscience.org/library/papers/36372281PubMed
1730922733Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study.Lancet Oncol2019https://conductscience.org/library/papers/30922733PubMed
1824439385Regulation of ferroptotic cancer cell death by GPX4.Cell2014https://conductscience.org/library/papers/24439385PubMed
1937646139Advances in immunotherapy for biliary tract cancers.Chin Med J (Engl)2024https://conductscience.org/library/papers/37646139PubMed
2023624327Preparation of isoliquiritigenin-loaded nanostructured lipid carrier and the in vivo evaluation in tumor-bearing mice.Eur J Pharm Sci2013https://conductscience.org/library/papers/23624327PubMed

See all 32 referencesDownload CSV of references

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
GPX42879PubTator's text mininghttps://conductscience.org/library/genes/2879NCBI Gene
HMOX13162PubTator's text mininghttps://conductscience.org/library/genes/3162NCBI Gene
KEAP19817PubTator's text mininghttps://conductscience.org/library/genes/9817NCBI Gene
NFE2L24780PubTator's text mininghttps://conductscience.org/library/genes/4780NCBI Gene
NUP6223636PubTator's text mininghttps://conductscience.org/library/genes/23636NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42226197

GET https://conductscience.org/api/papers/v1/42226197/references?page=2